BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29192952)

  • 41. Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age.
    Jaworska-Wilczyńska M; Natorska J; Siudut J; Marzec K; Kowalik I; Hryniewiecki T; Undas A
    Kardiol Pol; 2021; 79(7-8):796-803. PubMed ID: 34002842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive ability of the CHADS2 and CHA2DS2-VASc scores for stroke after transcatheter aortic balloon-expandable valve implantation: an Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) sub-analysis.
    Conrotto F; D'Ascenzo F; D'Onofrio A; Agrifoglio M; Chieffo A; Cioni M; Regesta T; Tarantini G; Gabbieri D; Saia F; Tamburino C; Ribichini F; Cugola D; Aiello M; Sanna F; Iadanza A; Pompei E; Stolcova M; Cappai A; Minati A; Cassese M; Martinelli GL; Agostinelli A; Gerosa G; Gaita F; Rinaldi M; Salizzoni S
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):867-873. PubMed ID: 27354254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence, Predictors and Impact of Severe Periprocedural Bleeding According to VARC-2 Criteria on 1-Year Clinical Outcomes in Patients After Transcatheter Aortic Valve Implantation.
    Kochman J; Rymuza B; Huczek Z; Kołtowski Ł; Ścisło P; Wilimski R; Ścibisz A; Stanecka P; Filipiak KJ; Opolski G
    Int Heart J; 2016; 57(1):35-40. PubMed ID: 26673439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of mitral stenosis on outcomes of aortic valve stenosis patient undergoing surgical aortic valve replacement or transcatheter aortic valve replacement.
    Al-Khadra Y; Darmoch F; Baibars M; Kaki A; Fanari Z; Alraies MC
    J Interv Cardiol; 2018 Oct; 31(5):655-660. PubMed ID: 29774601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive geriatric assessment in patients undergoing transcatheter aortic valve implantation - results from the CGA-TAVI multicentre registry.
    Ungar A; Mannarino G; van der Velde N; Baan J; Thibodeau MP; Masson JB; Santoro G; van Mourik M; Jansen S; Deutsch C; Bramlage P; Kurucova J; Thoenes M; Maggi S; Schoenenberger AW
    BMC Cardiovasc Disord; 2018 Jan; 18(1):1. PubMed ID: 29301486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
    Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
    Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of late mortality after transcatheter aortic valve implantation versus surgical aortic valve replacement: Insights from a meta-analysis.
    Ando T; Takagi H;
    Eur J Intern Med; 2017 May; 40():43-49. PubMed ID: 28162851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidetector CT predictors of prosthesis-patient mismatch in transcatheter aortic valve replacement.
    Freeman M; Webb JG; Willson AB; Wheeler M; Blanke P; Moss RR; Thompson CR; Munt B; Norgaard BL; Yang TH; Min JK; Poulsen S; Hansson NC; Binder RK; Toggweiler S; Hague C; Wood DA; Pibarot P; Leipsic J
    J Cardiovasc Comput Tomogr; 2013; 7(4):248-55. PubMed ID: 24148778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement.
    Généreux P; Cohen DJ; Mack M; Rodes-Cabau J; Yadav M; Xu K; Parvataneni R; Hahn R; Kodali SK; Webb JG; Leon MB
    J Am Coll Cardiol; 2014 Dec; 64(24):2605-2615. PubMed ID: 25524339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
    Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
    Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pacemaker implantation after TAVI: predictors of AV block persistence.
    Gaede L; Kim WK; Liebetrau C; Dörr O; Sperzel J; Blumenstein J; Berkowitsch A; Walther T; Hamm C; Elsässer A; Nef H; Möllmann H
    Clin Res Cardiol; 2018 Jan; 107(1):60-69. PubMed ID: 28963581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
    Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
    J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy.
    Furuta A; Lellouche N; Mouillet G; Dhanjal T; Gilard M; Laskar M; Eltchaninoff H; Fajadet J; Iung B; Donzeau-Gouge P; Leprince P; Leuguerrier A; Prat A; Dubois-Rande JL; Teiger E
    Int J Cardiol; 2016 May; 210():72-9. PubMed ID: 26930641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Propensity score matched comparison of transcatheter aortic valve implantation versus conventional surgery in intermediate and low risk aortic stenosis patients: A hint of real-world.
    Castrodeza J; Amat-Santos IJ; Blanco M; Cortes C; Tobar J; Martin-Morquecho I; López J; Di Stefano S; Rojas P; Varela-Falcon LH; Gomez I; San Roman JA
    Cardiol J; 2016; 23(5):541-551. PubMed ID: 27439368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.
    Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting hemorrhage and obstruction in the elderly population using thromboelastographic indices.
    Zheng Q; Fu S; Chen D; Li X; Li Y; Li Y; Yu J; Gong M; Bai J
    Clin Interv Aging; 2013; 8():1405-12. PubMed ID: 24204130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.